Professional Publications

Sovova, Z.; Suttnar, J.; Dyr, J.E.

Molecular dynamic simulations suggest that metabolite-induced post-translational modifications alter the behavior of the fibrinogen coiled-coil domain

[year of publication 2021, impact factor 4.932 ]

Malý, M.; Hajšl, M.; Bechyňská, K.; Kučerka, O.; Šrámek, M.; Suttnar, J.; Hlaváčková, A.; Hajšlová, J.; Kosek, V.

Lipidomic analysis to assess oxidative stress in acute coronary syndrome and acute stroke patients

[year of publication 2021, impact factor 4.932 ]

Kosek, V.; Hajšl, M.; Bechyňská, K.; Kučerka, O.; Suttnar, J.; Hlaváčková, A.; et al.

Long-term effects on the lipidome of acute coronary syndrome patients

[year of publication 2022, impact factor 4.932 ]

Brodska, H.; Drabek, T.; Malickova, K.; Kazda, A.; Vitek, A.; Zima, T.; Markova, M.

Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis : a prospective study

[year of publication 2009, impact factor 4.931]

Smith, E.M.; Pawlita, M.; Rubenstein, L.M.; Haugen, T.H.; Hamsikova, E.; Turek, L.P.

Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer

[year of publication 2009, impact factor 4.926]

Fucikova, J.; Podrazil, M.; Jarolim, L.; Bilkova, P.; Hensler, M.; Becht, E.; Gasova, Z.; et. al.

Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer

[year of publication 2018, impact factor 4.900 ]

Vyoral, D.; Petrak, J.

Therapeutic potential of hepcidin: the master regulator of iron metabolism

[year of publication 2016, impact factor 4.897 ]

Krijt, J.; Čmejla, R.; Sýkora, V.; Vokurka, M.; Vyoral, D.; Nečas, E.

Different expression pattern of hepcidin genes in the liver and pancreas of C57BL/6N and DBA/2N mice

[year of publication 2006, impact factor 4.816]

Hájková, H.; Fritz, M.H-Y.; Haškovec, C.; Schwarz, J.; Šálek, C.; Marková, J.; Krejčík, Z.; Dostálová Merkerová, M.; Kostečka, A.; Vostrý, M.; Fuchs, O.; Michalová, K.; Cetkovský, P.; Beneš, V.

CBFB - MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia

[year of publication 2014, impact factor 4.812 ]

Merkerova, M.; Vasikova, A.; Belickova, M.; Bruchova, H.

MicroRNA expression profiles in umbilical cord blood cell lineages

[year of publication 2009, impact factor 4.791]

Hamšíková, E.; Novák, J.; Hofmannová, V.; Muňoz, N.; Bosch, F.X.; De Sanjosé, S.; Shah, K.; Roth, Z.; Vonka, V.

Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls

[year of publication 2006, impact factor 4.781]

Smith, E. M.; Rubenstein, L. M.; Ritchie, J. M. ; Lee, J. H.; Haugen, T. H.; Hamsikova, E.; Turek, L. P.

Does pretreatment seropositivity to human papillomavirus have prognostic significance for head and neck cancers?

[year of publication 2008, impact factor 4.770]

Reuschenbach, M.; Waterboer, T.; Wallin, K. L.; Einenkel, J.; Dillner, J.; Hamsikova, E.; Eschenbach, D.; Zimmer, H.; Heilig, B.; Kopitz, J.; Pawlita, M.; Doeberitz, M. V.; Wentzensen, N.

Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers

[year of publication 2008, impact factor 4.734]

Brezinova, J.; Sarova, I.; Buryova, H.; Markova, J.; Ransdorfova, S.; Izakova, S.; Kostylkova, K.; Soukupova, J.; Zemanova, Z.; Michalova, K.

Fusion of the additional sex combs like 1 and teashirt zinc finger homeobox 2 genes resulting from ider(20q) aberration in a patient with myelodysplastic syndrome

[year of publication 2013, impact factor 4.711 ]

Mojzikova, R.; Koralkova, P.; Holub, D.; Zidova, Z.; Pospisilova, D.; Cermak, J.; Striezencova Laluhova, Z.; Indrak, K.; Sukova, M.; Partschova, M.; Kucerova, J.; Horvathova, M.; Divoky, V.

Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios

[year of publication 2014, impact factor 4.711 ]

Plasilova, M.; Zivny, J.; Jelinek, J.; Neuwirtova, R.; Cermak, J.; Necas, E.; Andera, L.; Stopka, T.

TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors

[year of publication 2006, impact factor 4.693]

Smith, E.M.; Ritchie, J.M.; Pawlita, M.; Rubenstein, L.M.; Haugen, T.H.; Turek, L.P.; Hamsikova, E.

Human papillomavirus seropositivity and risks of head and neck cancer

[year of publication 2007, impact factor 4.693]

Divoky, V.; Song, J.; Horvathova, M.; Kralova, B.; Votavova, H.; Prchal, J.T.; Yoon, D.

Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor

[year of publication 2016, impact factor 4.686 ]

Racil, Z.; Buresova, L.; Brejcha, M.; Prochazkova, J.; Zounar, R.; Timilsina, S.; Razga, F.; Toskova, M.; Cetkovsky, P.; Mayer, J.

Clinical and laboratory features of leukemias at the time of diagnosis: an analysis of 1,004 consecutive patients.

[year of publication 2011, impact factor 4.671 ]

Zackova, D.; Klamova, H.; Dusek, L.; Muzik, J.; Machova Polakova, K.; Moravcova, J.; Jurcek, T.; Dvorakova, D.; Racil, Z.; Pospisil, Z.; Oltova, A.; Michalova, K.; Brezinova, J.; Razga, F.; Doubek, M.; Cetkovsky, P.; Trneny, M.; Mayer, J.

Imatinib as the first line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials?

[year of publication 2010, impact factor 4.671 ]